Laurus Labs receives in-principle approval (Tentative Approval) from USFDA to launch the world’s first Oral Dispersible Film (ODF) drug, Dolutegravir, for treating HIV/AIDS in kids and infants. This innovative ODF technology drug (NDA #215319 ) will simplify drug administration in children Read More..